Vered Bisker-Leib
2022
In 2022, Vered Bisker-Leib earned a total compensation of $1.7M as Chief Executive Officer formerly President and COO at Compass Therapeutics, a 61% decrease compared to previous year.
Compensation breakdown
| Bonus | $320,000 |
|---|---|
| Option Awards | $918,306 |
| Salary | $475,000 |
| Other | $11,433 |
| Total | $1,724,739 |
Bisker-Leib received $918.3K in option awards, accounting for 53% of the total pay in 2022.
Bisker-Leib also received $320K in bonus, $475K in salary and $11.4K in other compensation.
Rankings
In 2022, Vered Bisker-Leib's compensation ranked 1,991st out of 5,760 executives tracked by ExecPay. In other words, Bisker-Leib earned more than 65.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,991 out of 5,760 | 65th |
Division Manufacturing | 1,061 out of 3,136 | 66th |
Major group Chemicals And Allied Products | 453 out of 1,422 | 68th |
Industry group Drugs | 415 out of 1,323 | 69th |
Industry Biological Products, Except Diagnostic Substances | 102 out of 291 | 65th |
Source: SEC filing on April 29, 2024.
Bisker-Leib's colleagues
We found one more compensation record of an executive who worked with Vered Bisker-Leib at Compass Therapeutics in 2022.
2022
Thomas Schuetz
Compass Therapeutics